TABD Companies Urge Governments to Drive Innovation

The TransAtlantic Business DialogueThe TransAtlantic Business Dialogue (TABD) held its Innovation Conference Healthcare under the patronage of German Chancellor Angela Merkel, who has made transatlantic innovation a key tenet of the EU presidency. The conference, which brought together American and European participants, including political leaders and scientific experts, presented four recommendations to improve innovation in healthcare and healthcare delivery.

Speakers at the TABD conference, noting aging demographics and escalating healthcare costs on both sides of the Atlantic, urged the European Union and the U.S. Government to:

  • Recognize healthcare as an infrastructure component that serves as both the means to improve people's health and well-being and a key economic driver;
  • Accelerate the deployment of healthcare innovations by harmonizing standards, streamlining approval processes and protecting intellectual property rights;
  • Foster innovation and redirect financial incentives to focus on prevention, early detection and continuity of care; and
  • Establish an expert panel to develop benchmarking and best practices, working with the European Commission, the U.S. Government and the TABD Innovation Working Group.

Among OECD countries, the healthcare sector will more than triple to $10 trillion by 2020, according to "HealthCast 2020: Creating a Sustainable Future," a report by PricewaterhouseCoopers. The report stated that the healthcare sector is challenged by a confluence of powerful trends that include increasing demands, rising costs, uneven quality and misaligned incentives.

"Our aging populations and rising demand for higher-quality care accentuate the inefficiencies across the healthcare spectrum," said Klaus Kleinfeld, President and CEO of Siemens AG and Co-Chair of the TABD Innovation Working Group. "Consequently, we need to put the patient at the center of an improved healthcare system by developing and deploying innovations in technology and service delivery."

Richard T. Clark, Chairman, President and CEO of Merck & Co., Inc. (USA) and Cochair of the Innovation Working Group called for developing new ways of thinking about healthcare investment and spending. "Advances in medical technology and patient care set the stage to deliver prevention instead of treatment. As we build this capability, we want governments and other financial providers to think of healthcare spending as an investment that should be encouraged – not as a cost to be managed."

Speakers at the event included German Federal Minister of Education and Research Annette Schavan; European Commission Vice President Günter Verheugen; Deputy Secretary of the U.S. Department of Commerce David A. Sampson, Hans Hoogervorst former Minister of Health, Welfare and Sports, The Netherlands; and Newt Gingrich, Founder of the Center for Health Transformation and former Speaker, U.S. House of Representatives.

About the TransAtlantic Business Dialogue Innovation Conference Healthcare
As Co-Chairmen of the TransAtlantic Business Dialogue (TABD) Innovation Working Group Klaus Kleinfeld, CEO Siemens AG, and Richard Clark, Chairman, President and CEO of Merck & Co. Inc. (USA) co-hosted the TABD Innovation Conference Healthcare in Berlin on May 8, 2007. The TABD Innovation Conference was organized by the TABD and sponsored by AstraZeneca, General Electric, Microsoft, Merck Sharp & Dohme (MSD), Pfizer, Philips, PricewaterhouseCoopers and Siemens AG.

About the TransAtlantic Business Dialogue
The TABD brings together the CEOs of more than 30 European and U.S. companies operating in the United States, Europe and globally, with the aim of promoting closer commercial ties between the US and the European Union. The current TABD Chairmen are Martin Broughton, Chairman of British Airways and Charles Prince, Chairman and Chief Executive Officer of Citigroup. Originally launched with the support of the U.S. Department of Commerce and the European Commission in Seville in 1995, it was relaunched in a new format in 2003. The TABD is a unique and effective organization whose primary goal is to help establish a barrier-free transatlantic market with the freest possible exchange of goods, services and capital between the EU and US. The TABD advocates global trade liberalization as a means to greater prosperity for all countries, which in turn will help stimulate innovation, investment, economic growth, and job creation.

For further information, please visit:

Related news articles::

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...